April 4, 2019 / 5:59 PM / 8 months ago

Health Canada plans to suspend Allergan's breast implant license

April 4 (Reuters) - The Canadian health regulator said on Thursday it was advising Allergan Plc that it plans to suspend the license for the Botox-maker’s Biocell breast implants.

Health Canada said its move followed the completion of its assessment of textured breast implants as part of a larger ongoing safety review. (Reporting by Manas Mishra in Bengaluru; Editing by James Emmanuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below